Nephros Inc (NEPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 3,742 | 3,545 | 3,697 | 2,557 | 2,409 |
| Cost of Goods | 1,548 | 1,466 | 1,586 | 1,036 | 1,647 |
| Gross Profit | 2,194 | 2,079 | 2,111 | 1,521 | 762 |
| Operating Expenses | 2,945 | 2,980 | 3,003 | 2,250 | 2,690 |
| Operating Income | -203 | -435 | -306 | -693 | -1,281 |
| Interest Expense | 0 | 0 | 1 | 3 | 4 |
| Other Income | 21 | 2 | 1 | -23 | 35 |
| Pre-tax Income | -182 | -433 | -306 | -719 | -1,250 |
| Net Income Continuous | -182 | -433 | -306 | -719 | -1,250 |
| Net Income Discontinuous | N/A | N/A | N/A | -129 | -1,904 |
| Minority Interests | N/A | N/A | N/A | 70 | 77 |
| Net Income | $-182 | $-433 | $-306 | $-918 | $-3,231 |
| EPS Basic Total Ops | -0.02 | -0.04 | -0.03 | -0.13 | -0.30 |
| EPS Basic Continuous Ops | -0.02 | -0.04 | -0.03 | -0.11 | -0.12 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.02 | -0.18 |
| EPS Diluted Total Ops | -0.02 | -0.04 | -0.03 | -0.13 | -0.30 |
| EPS Diluted Continuous Ops | -0.02 | -0.04 | -0.03 | -0.11 | -0.12 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.02 | -0.18 |
| EBITDA(a) | $-147 | $-382 | $-252 | $-638 | $-1,181 |